ArticleAsian Pacific journal of cancer prevention : APJCP2025
PTEN and HES1 Gene Expression Alteration in Breast Cancer: Any Association with Tumor Histomorphological Features or Invasive Behavior?
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGenomic techniques and the evaluation of epigenetic and proteomic alterations are increasingly used to predict breast tumors' behavior and histopathological patterns. While some studies have linked PTEN and HES1 gene expression to tumor aggressiveness and metastatic behavior, others have not confirmed these associations. This study aimed to assess PTEN and HES1 gene expression in breast cancer lesions and explore their relationship with tumor morphological features and behavior.
methodsThis cross-sectional study involved 50 women with breast cancer. Tumor and adjacent normal breast tissue (50 each) were collected to assess PTEN and HES1 gene expression using Real-Time PCR. RNA extraction was performed using the Trizol method, followed by cDNA synthesis. Gene expression changes were quantified using the ΔΔCT method. Statistical analysis was conducted using SPSS version 23.0, with significance set at p ≤ 0.05.
resultsPTEN down-regulation was observed in 70.0%, and HES1 up-regulation in 98.0% of cases. No significant association was found between PTEN down-regulation and tumor-related characteristics, except for a significantly higher mean age in patients with down-regulated PTEN (p = 0.003). HES1 expression intensity, with a mean fold change of 6.193 (median: 4.560, SD: 5.116), showed no significant relationship with any histopathological features or invasive behavior.
conclusionOlder patients showed reduced PTEN expression. Additionally, elevated HES1 was identified in 98% of patients and lower PTEN in 70%. However, these gene alterations do not seem to reliably predict aggressive tumor behavior in our population, possibly due to the limited sample size. Further studies with long-term follow-up are needed to fully evaluate the prognostic significance of these markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.